Showing results (411-420 of 553) with videos related to

Sort By:
Pageof 56
Drugs in Context|May 28, 2026
Body composition and cardiometabolic risk reduction following therapy with a multi-ingredient nutraceutical formulation: a real-life clinical studyAnna Maria Sironi, Michela Franchini, Vittoria Tessieri, et al.
Drugs in Context|May 20, 2026
Efficacy and safety of Serenoa repens in benign prostatic disorders: a systematic review of recent clinical evidenceIván Schwartzmann, Anna Redondo, Alba Farré, et al.
Drugs in Context|June 17, 2026
GLP1 receptor agonists in heart failure with preserved ejection fraction (HFpEF) - beyond weight loss: a condensed scientific reviewElyzabeth Roy, Marie-Claude Parent, Anique Ducharme
Drugs in Context|June 29, 2026
Deucravacitinib in dermatology: current indication and existing off-label dataMichela D'Agostino, Luca Potestio, Nello Tommasino, et al.
Drugs in Context|September 19, 2022
The prognostic role of variations in tumour markers (CEA, CA15.3) in patients with metastatic breast cancer treated with CDK4/6 inhibitorsFederico Sottotetti, Elisa Ferraris, Barbara Tagliaferri, et al.
Drugs in Context|April 27, 2016
Human plasma-derived FVIII/VWD concentrate (Biostate): a review of experimental and clinical pharmacokinetic, efficacy and safety dataPaul Harper, Emmanuel J Favaloro, Julie Curtin, et al.
Drugs in Context|October 29, 2024
Pharmacovigilance monitoring and treatment adherence in patients on antihypertensive drugs at a tertiary care centrePooja Agrawal, Shilpa Patrick, Meenu Thomas, et al.
Drugs in Context|November 5, 2025
JAK inhibitors for the treatment of palmoplantar pustulosis: a narrative reviewBeatriz Henriques Dos Santos, João Domingues, Marco Sousa, et al.
Drugs in Context|November 5, 2025
Place in therapy of key treatments for platinum-sensitive, relapsed, extensive-stage small cell lung cancer with a focus on lurbinectedin: a narrative review with case studiesLeonid Shunyakov, Firas B Badin, Judith Hafer, et al.
Drugs in Context|September 29, 2025
10 years of real-world data: long-term efficacy and safety of HyalOne® for hip osteoarthritisAlberto Migliore, Nazzareno Iannarelli, Luca Saccone, et al.
Pageof 56